Nippon rinsho. Japanese journal of clinical medicine

(ISSN: 0047-1852)

Table of Contents

2012 - 70 Suppl 7

  • [Economic evaluation of treatment on breast cancer]. 
  • [Interdisciplinary team clinical practice in recurrent breast cancer]. 
  • [Collaboration between oncologist and family physicians for the use of a regional cooperation booklet]. 
  • [Current status and problems of breast cancer screening in Japan]. 
  • [Significance of participation of global clinical trial]. 
  • [The significance of JROSG (Japanese Radiation Oncology Study group) 05-5 Study]. 
  • [Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]. 
  • [The point of the informed consent in a breast cancer chemotherapy]. 
  • [Point of informed consent on breast cancer surgical treatments]. 
  • [Elements of informed consent in patients with diagnosed breast cancer]. 
  • [Areal medical cooperation for the treatment of breast cancer to improve quality of life of patients]. 
  • [Financial difficulties and health-related quality of life in breast cancer patients]. 
  • [QOL of young breast cancer patients]. 
  • [Late adverse effects and QOL after breast conserving therapy]. 
  • [Measuring quality of life in patients with breast cancer]. 
  • [Today and future perspectives in breast cancer immunotherapy]. 
  • [Experimental basic research on mammary cancer gene therapy for metastasis inhibition]. 
  • [Breast surgery and biopsy in anticoagulated patients]. 
  • [Management of the breast cancer in patients with mental illness]. 
  • [Chemotherapy for elderly breast cancer]. 
  • [Stage I-III breast cancer in elderly patients]. 
  • [Supports for the toxicity of the molecular target medicine]. 
  • [Management for treatment-induced adverse reaction--chemotherapy]. 
  • [Dry skin of breast after breast conserving therapy (frequency and measures)]. 
  • [Utility of skin-sparing mastectomy]. 
  • [Immediate breast reconstruction after mastectomy using tissue expandable implants]. 
  • [Immediate latissimus breast reconstruction with nipple reconstruction]. 
  • [Immediate mammoplasty using lateral tissue flap after breast-conserving surgery]. 
  • [Evaluation of cohesive silicone breast implants]. 
  • [Endocrine therapy for advanced breast cancer]. 
  • [Adjuvant endocrine therapy for postmenopausal women]. 
  • [Adjuvant endocrine therapy in premenopausal breast cancer]. 
  • [Anti-angiogenic therapy for breast cancer--problems and future directions]. 
  • [Anti-Her2 therapy in breast cancer]. 
  • [Individualized treatment of breast cancer chemotherapy]. 
  • [Clinical utility of adjuvant TC regimen]. 
  • [Oral combination chemotherapy with capecitabine and cyclophosphamide in combination with endocrine therapy and anti-HER2 therapy for advanced and metastatic breast cancer]. 
  • [Oral chemotherapy for advanced breast cancer]. 
  • [Treatment of inoperable breast cancer]. 
  • [Principal strategy for metastatic breast cancer]. 
  • [Multidisciplinary treatment of chemotherapy and surgical therapy]. 
  • [Prediction of therapeutic efficacy for preoperative chemotherapy]. 
  • [Radiofrequency ablation for early breast cancer]. 
  • [Implication of radiotherapy for locoregional recurrence of breast cancer]. 
  • [Proposed measures for the complication after breast irradiation]. 
  • [Indication of chemoradiotherapy in patients with unresectable T4 breast tumors]. 
  • [PMRT(post-mastectomy radiation therapy)]. 
  • [Intraoperative radiotherapy for early breast cancer]. 
  • [Role of radiotherapy in breast-conserving therapy]. 
  • [Breast-conserving surgery for ductal carcinoma in situ of the breast]. 
  • [A novel method to determine the suitable dissection line using sutures in breast-conserving surgery]. 
  • [Surgical methods and indications for local recurrence of breast cancer]. 
  • [Radioguided occult lesion localization for non palpable breast cancer]. 
  • [MRI diagnosis for the planning of breast-conserving surgery]. 
  • [Oncoplastic surgery for patients with ptotic breast cancer]. 
  • [Ipsilateral breast tumor recurrence after breast conserving surgery]. 
  • [Video-assisted surgery for early breast cancer]. 
  • [Surgical treatment strategy for early breast cancer]. 
  • [Breast cancer practice guideline 2011]. 
  • [Problem of the hereditary breast cancer screening; including the genetic diagnosis]. 
  • [Importance and practice of UGT1A1 polymorphisms]. 
  • [Predictive factors for endocrine responsiveness in stage IV breast cancer]. 
  • [Circulating endothelial cells(CECs), circulating endothelial progenitors (CEPs)]. 
  • [Identification of a novel serum marker for early breast cancer detection by proteomic approach]. 
  • [ALDH1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with node-positive breast cancer]. 
  • [Galectin-9 as a possible suppressor for metastasis of breast cancer]. 
  • [L-type amino acid transporter 1 (LAT1)]. 
  • [FOXA1 expression in luminal-type breast cancer]. 
  • [Endocrine responsiveness based on expression levels of ki67]. 
  • [Ki67 immunohistochemical staining: the present situation of diagnostic criteria]. 
  • [Dual color in situ hybridization in HER2 testing]. 
  • [Quality assurance in HER2 testing]. 
  • [Indeterminate case of breast fine-needle aspiration biopsy]. 
  • [Assessment of histopathological markers for response to primary systemic therapy]. 
  • [Histopathological diagnosis of surgical margins and sentinel lymph nodes]. 
  • [Imprint cytology from core biopsies for breast lesions]. 
  • [Management for treatment of lobular carcinoma in situ (LCIS)]. 
  • [Atypical lobular hyperplasia (ALH)]. 
  • [Base of pathological reporting for breast carcinoma and appropriate management for the excised specimen]. 
  • [Intra-operative rapid diagnosis of sentinel lymph node metastases by the one-step nucleic acid amplification]. 
  • [3D-CT mammary lymphography for sentinel node biopsy]. 
  • [Sentinel lymph node biopsy in the neoadjuvant setting]. 
  • [Sentinel lymph node biopsy using ICG fluorescence navigation method]. 
  • [Dye-guided sentinel node biopsy for breast cancer]. 
  • [Sentinel lymph node biopsy with predict factors to omit axillary lymph node dissection]. 
  • [Sentinel lymph node biopsy under local anaesthesia for outpatient]. 
  • [The utility of FDG-PET/CT for pre/post operative diagnosis]. 
  • [Ductal carcinoma in situ (DCIS) on B-mode breast ultrasound sonography (US)]. 
  • [Contrast-enhanced ultrasonography using by sonazoid (spread diagnosis)]. 
  • [Photoacoustic mammography for the diagnosis of breast cancer]. 
  • [Ultrasound features of triple negative breast cancer]. 
  • [MRI and sonography imaging fusion system with magnetic position tracking system using real-time virtual sonography (RVS) for second-look US of the breast]. 
  • [Accuracy for a diagnosis of breast cancer spread using 3.0T MRI]. 
  • [VAB (vacuum-assisted breast biopsy system)]. 
  • [Assessment of ductal spread extent of breast cancer with MDCT]. 
  • [Ultra early phase MRI for non-palpable breast cancer microcalcification in supine position]. 
  • [Are the images for delineating tumor extent inside breast for breast cancer patients necessary ?--Challenges by the multiinstitutional prospective study on breast CT]. 
  • [Diagnosis of metachronous bilateral breast cancer]. 
  • [Medical relations in breast cancer screening program]. 
  • [Close examination of mammographically detected microcalcifications]. 
  • [Diagnostic process of the distorted lesion detected by mammography]. 
  • [Diagnosis procedures for breast cancer]. 
  • [Breast imaging analysis and diagnosis: introduction]. 
  • [Therapeutic strategy for breast cancer stem cells]. 
  • [Genetic diagnosis of familial breast cancer]. 
  • [Clinical implementation of the immunohistochemical intrinsic subtypes of breast cancer]. 
  • [Gene expression profiling studies in breast cancer]. 
  • [Application of microRNA to breast cancer diagnosis]. 
  • [Activation of aromatase gene expression by RORalpha and GR expression in breast cancer tissue]. 
  • [Mechanistic analysis of the antitumor efficacy of TRAIL-positive human natural killer cells]. 
  • [Epithelial-mesenchymal transition and tumor microenvironment propose the seed and soil theory of the present age]. 
  • [Comparison of clinical guidelines between Japanese Breast Cancer Society and National Comprehensive Cancer Network]. 
  • [Comparison among Japanese general rules for clinical and pathological recording of breast cancer 16th eds and UICC TNM classification 7th eds]. 
  • [General view on classifications, staging systems and treatment guidelines]. 
  • [Ki-67 labeling index as prognostic in breast cancer]. 
  • [Loss of heterozygosity (LOH) at BRCA1 loci in primary breast cancers]. 
  • [HOXB9 as a novel prognostic factor in breast cancer]. 
  • [The significance for prognostic factor of pathological complete response (pCR) after neoadjuvant chemotherapy]. 
  • [Bmi-1 expression in breast cancer]. 
  • [Prognostic significance of the number of axillary lymph nodes examined in breast cancer]. 
  • [Outline of prognostic factors and their clinical relevance in breast cancer]. 
  • [The clinical features of meningeal dissemination from breast cancer]. 
  • [Clinical significances of metastasis to stomach or uterus, from breast cancers]. 
  • [Clinical characteristic of brain metastases from breast cancer]. 
  • [Clinical features of lung metastases from breast cancer]. 
  • [Clinical features of hepatic metastasis from breast cancer]. 
  • [Clinical characteristics of bone metastases of breast cancer]. 
  • [Mechanisms of invasion and metastasis in human breast carcinoma]. 
  • [Genetic polymorphisms and breast cancer]. 
  • [Second malignancies in breast cancer patients after radiotherapy]. 
  • [Mechanisms of human breast cancer tumorigenesis: outline (including the molecular mechanism and multi-step of breast carcinogenesis)]. 
  • [Chemoprevention for breast cancer]. 
  • [The significance of microRNA in breast cancer cells]. 
  • [LOH and genetic polymorphysms of breast cancer]. 
  • [Oncogene and tumor suppressor gene]. 
  • ['Molecular biology' of breast cancer]. 
  • [Familial breast cancer and hereditary breast cancer]. 
  • [Risk factors of breast cancer (life style and environmental factors)]. 
  • [Epidemiological features of breast cancer with special reference of global pattern]. 
  • [Recent trends of breast cancer epidemiology in Japan]. 
  • [Change and perspective in endocrine therapy]. 
  • [Transition and perspective of chemotherapy in breast cancer]. 
  • [Survey of the history and the future for breast cancer radiotherapy]. 
  • [History and future of surgical treatment]. 
  • [Tradition and prospect of pathological diagnosis]. 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.